conducted a study investigating the spatial structure of the liver cancer microenvironment and revealed that interactions between CAFs and SPP1+ macrophages facilitate ECM accumulation through ligand-receptor interactions, thereby influencing the efficacy of immunotherapy for liver cancer (3). The gene discussed is SPP1; the disease is liver cancer.